Media

January 9, 2025: MaaT Prepares For EMA Filing, US Expansion After Positive GVHD Readout – SCRIP

Date : January 27, 2025

To see the article click here

January 9, 2025: MaaT’s phase 3 GvHD trial hits goal, teeing up microbiome filing if cash crunch clears – Fierce Biotech

January 9, 2025: Microbiote: résultats positifs d’une étude clinique de MaaT Pharma – Agence France Presse (French Only)